Xian Zhang
8PUBLICATIONS
32CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 20, 2025
Immune reconstitution after CD7 CAR-T cell therapy for refractory/relapsed acute T-lymphoblastic leukaemia/lymphoblastic lymphoma (R/R T-ALL/LBL).Xian Zhang, Lin Wang, Na Kuang
|Aug 14, 2025
Epidemiology, clinical features, and molecular basis of TTMV::RARA-driven acute promyelocytic leukemia.Xiaosu Zhou, Jiaqi Chen, Yan-Lai Tang
|Jun 26, 2025
Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma.Xian G Zhang, Lin Wang, Junfang Yang
|Nov 19, 2024
Nanobody-based naturally selected CD7-targeted CAR-T therapy for acute myeloid leukemia.Peihua Lu, Xian Zhang, Junfang Yang
|Jul 24, 2024
Critical role of tripartite fusion and LBD truncation in certain RARA- and all RARG-related atypical APL.Xiaosu Zhou, Xue Chen, Jiaqi Chen
|Apr 13, 2024
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T-cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T-cell therapy.Xing-Yu Cao, Jian-Ping Zhang, Yue Lu
Pageof 2